News

A new report reveals that gastrointestinal cancer rates are rising in young adults, with "Western diet" and lifestyle factors ...
News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER. BC, July 16, 2025 /CNW/ — As lawmakers weigh potential cuts to scientific research ...
Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the 'Company” or 'Qualigen”) is announcing an update on patents granted in the ...
Qualigen Therapeutics (NASDAQ:QLGN) saw its stock jump 80% following news that it secured new patents spanning 25 countries for its cancer drug QN-302. The patents, titled “Substituted Naphthalene ...
A study published by Caris showed that certain tumor types had very low or no HER2 overexpression, which has implications for biomarker testing strategies.